Chronic rhinosinusitis (CRS) describes a heterogenous group of diseases including CRS with (CRSwNP) or without nasal polyps (CRSsNP), aspirin-exacerbated respiratory disease (AERD), and allergic fungal rhinosinusitis (AFRS). It affects 10 to 15% of the US population and is more common in women and White patients. However, these estimates are based on survey and database studies with innate diagnostic inaccuracy. Additionally, few studies report subtype-specific demographics. We explore the demographic differences of CRS in the U.S. by subtype and region.
Objective
To characterize demographic differences between the CRS population and the overall US population, and also between different CRS subtype populations.
Methods
We performed a systematic review for articles reporting on US demographics of adults with CRS. Study participants were required to have been diagnosed using consensus criteria. Data on demographics, geographic region, and CRS subtype were analyzed.
Results
Our study analyzed 31 unique studies representing 8409 patients with 50.7% females and weighted mean age of 48.0 years. Compared to the overall US population, CRS patients were predominantly White (78.5%) and non-Hispanic (94.5%) with under-representation of other races. Grouped by subtype, CRSwNP affected a significantly higher proportion of men (59.8%). AFRS affected a significantly higher proportion of Black patients (53.8%) while CRSsNP was more prevalent in White patients (84.2%). When grouped by region, the South had a significantly higher proportion of female (53%) and Black (17.8%) CRS patients. The West had a significantly higher proportion of Asian (4.5%) and Hispanic (12.3%) patients.
Conclusions
Significant demographic differences exist in CRS patients based on subtype and region. These data provide an estimation of the demographic make-up of CRS, but further high-level demographic studies are needed.
ChoSHHamilosDLHanDH, et al. Phenotypes of chronic rhinosinusitis. J Allergy Clin Immunol Pract. 2020;8(5):1505–1511.
2.
RudmikLSmithTL. Quality of life in patients with chronic rhinosinusitis. Curr Allergy Asthma Rep.2011;11(3):247–252.
3.
BhattacharyyaN. Incremental health care utilization and expenditures for chronic rhinosinusitis in the United States. Annals of Otology, Rhinology & Laryngology. 2011;120(7):423–427.
4.
RudmikLSmithTLSchlosserRJ, et al. Productivity costs in patients with refractory chronic rhinosinusitis. Laryngoscope.2014;124(9):2007–2012.
5.
RosenfeldRMAndesDBhattacharyyaN, et al. Clinical practice guideline: adult sinusitis. Otolaryngol Head Neck Surg. 2007;137(3 Suppl):S1–31.
6.
FokkensWLundVMullolJ. European position paper on rhinosinusitis and nasal polyps 2007. Rhinol Suppl. 2007;20:1–136.
7.
DeCondeASSolerZM. Chronic rhinosinusitis: epidemiology and burden of disease. Am J Rhinol Allergy. 2016;30(2):134–139.
8.
BhattacharyyaN. Clinical and symptom criteria for the accurate diagnosis of chronic rhinosinusitis. Laryngoscope.2006;116(S110):1–22.
9.
XiaoCCAndersonMHarlessLD, et al. Shortcomings in the diagnosis of chronic rhinosinusitis: evaluating diagnosis by otolaryngologists and primary care physicians. Int Forum Allergy Rhinol. 2018;8(10):1107–1113.
10.
LuiJTRudmikL. Case definitions for chronic rhinosinusitis in administrative data: a systematic review. Am J Rhinol Allergy. 2015;29(5):e146–e151.
Higgins JPTTJChandlerJCumpstonMLiTPageMJWelchVA. Cochrane Handbook for Systematic Reviews of Interventions Version 6.0. Published 2019. Accessed September 6, 2020.
14.
SterneJAHernánMAReevesBC, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Br Med J.2016;355(1):i4919.
15.
BentJP3rdKuhnFA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg. 1994;111(5):580–588.
16.
Census Regions and Divisions of the United States. Census.gov: United States Census Bureau, 2010.
BanoubRGHoehleLPPhillipsKM, et al. Depressed mood modulates impact of chronic rhinosinusitis symptoms on quality of life. The Journal of Allergy and Clinical Immunology: In Practice. 2018;6(6):2098–2105.
20.
ChapurinNLiPChandraRK, et al. Elevated mucus interleukin-17A levels are associated with increased prior sinus surgery for chronic rhinosinusitis. Int Forum Allergy Rhinol.2021;11(2):120–127.
21.
DuersonWLaferMAhmedO, et al. Health care disparities in patients undergoing endoscopic Sinus surgery for chronic rhinosinusitis: differences in disease presentation and access to care. Annals of Otology, Rhinology & Laryngology. 2019;128(7):608–613.
22.
FerenceEHStubbsVLidderAK, et al. Measurement and comparison of health utility assessments in chronic rhinosinusitis. Int Forum Allergy Rhinol.2015;5(10):929–936.
23.
GardnerJRCampbellJBDaigleO, et al. Operative and postoperative outcomes in elderly patients undergoing endoscopic sinus surgery. Eur Arch Oto-Rhino-Laryngol.2021;278(5):1471–1476.
24.
GhadersohiSPriceCPEJensenSE, et al. Development and preliminary validation of a New patient-reported outcome measure for chronic rhinosinusitis (CRS-PRO). The Journal of Allergy and Clinical Immunology: In Practice. 2020;8(7):2341–2350.e2341.
25.
HesslerJLPiccirilloJFFangD, et al. Clinical outcomes of chronic rhinosinusitis in response to medical therapy: results of a prospective study. Am J Rhinol.2007;21(1):10–18.
26.
HigginsTSÖcalBAdamsR, et al. “In-Office balloon Sinus ostial dilation with concurrent antiplatelet and anticoagulant therapy for chronic rhinosinusitis without nasal polyps”. Annals of Otology, Rhinology & Laryngology. 2020;129(3):280–286.
27.
Staniorski CJohnPriceCPEWeibmanAR, et al. Asthma onset pattern and patient outcomes in a chronic rhinosinusitis population. Int Forum Allergy Rhinol.2018;8(4):495–503.
28.
LeeSEFarquharDRAdamsKN, et al. Effect of zileuton treatment on sinonasal quality of life in patients with aspirin-exacerbated respiratory disease. Am J Rhinol Allergy.2019;33(6):791–795.
29.
LevineCGDavisGEWeaverEM. Functional comorbidity Index in chronic rhinosinusitis. Int Forum Allergy Rhinol.2016;6(1):52–57.
30.
LinDCChandraRKTanBK, et al. Association between severity of asthma and degree of chronic rhinosinusitis. Am J Rhinol Allergy.2011;25(4):205–208.
31.
LittleRESchlosserRJSmithTL, et al. Disease control after surgery for chronic rhinosinusitis: prospective, multi-institutional validation of the Sinus Control Test. Int Forum Allergy Rhinol.2021;11(2):106–114.
32.
LitvackJRMaceJCSmithTL. Olfactory function and disease severity in chronic rhinosinusitis. Am J Rhinol Allergy.2009;23(2):139–144.
33.
LoftusCASolerZMDesiatoVM, et al. Factors impacting revision surgery in patients with chronic rhinosinusitis with nasal polyposis. Int Forum Allergy Rhinol.2020;10(3):289–302.
34.
Lu-MyersYDealAMMillerJD, et al. Comparison of socioeconomic and demographic factors in patients with chronic rhinosinusitis and allergic fungal rhinosinusitis. Otolaryngology–Head and Neck Surgery. 2015;153(1):137–143.
35.
RyanWRRamachandraTHwangPH. Correlations between symptoms, nasal endoscopy, and in-office computed tomography in post-surgical chronic rhinosinusitis patients. Laryngoscope.2011;121(3):674–678.
36.
SamuelsonMBChandraRKTurnerJH, et al. The relationship between social determinants of health and utilization of tertiary rhinology care. Am J Rhinol Allergy.2017;31(6):376–381.
37.
ScangasGABleierBSHusainQ, et al. Does bilateral inferior turbinate reduction affect long-term quality-of-life outcomes in patients undergoing endoscopic sinus surgery?Int Forum Allergy Rhinol.2019;9(6):601–606.
38.
SchulerCFBaldwinJLBaptistAP. Frequency and severity of reactions to a 325-mg aspirin dose during desensitization. Ann Allergy Asthma Immunol.2017;118(3):333–338.e331.
39.
ShenSAJafariAQualliotineJR, et al. Socioeconomic and demographic determinants of postoperative outcome after endoscopic sinus surgery. Laryngoscope.2020;130(2):297–302.
40.
SmithKAAshbySOrlandiRR, et al. The price of pain in chronic rhinosinusitis. Int Forum Allergy Rhinol.2018;8(8):907–912.
41.
SmithTLLitvackJRHwangPH, et al. Determinants of outcomes of sinus surgery: a multi-institutional prospective cohort study. Otolaryngology–Head and Neck Surgery. 2010;142(1):55–63.
42.
StevensWWPetersATSuhL, et al. A retrospective, cross-sectional study reveals that women with CRSwNP have more severe disease than men. Immun Inflamm Dis.2015;3(1):14–22.
43.
SweisAMLockeTBIg-IzevbekhaiKI, et al. Major complications of aspirin desensitization and maintenance therapy in aspirin-exacerbated respiratory disease. Int Forum Allergy Rhinol.2021;11(2):115–119.
44.
TammemagiCMDavisRMBenninger MS., et al. Secondhand smoke as a potential cause of chronic rhinosinusitis: a case-control study. Arch Otolaryngol Head Neck Surg.2010;136(4):327–334.
45.
VelasquezNThambooAHabibA-RR, et al. The empty nose syndrome 6-item questionnaire (ENS6Q): a validated 6-item questionnaire as a diagnostic aid for empty nose syndrome patients. Int Forum Allergy Rhinol.2017;7(1):64–71.
46.
WiseSKGheganMDGorhamE, et al. Socioeconomic factors in the diagnosis of allergic fungal rhinosinusitis. Otolaryngology–Head and Neck Surgery. 2008;138(1):38–42.
47.
WitsellDLStewartMGMonsellEM, et al. The cooperative outcomes group for ENT: a multicenter prospective cohort study on the effectiveness of medical and surgical treatment for patients with chronic rhinosinusitis. Otolaryngology–Head and Neck Surgery. 2005;132(2):171–179.
48.
YooFFerenceEHKuanEC, et al. Evaluation of patient nasal saline irrigation practices following endoscopic sinus surgery. Int Forum Allergy Rhinol.2018;8(1):32–40.
49.
ZhangZAdappaNDDoghramjiLJ, et al. Quality of life improvement from sinus surgery in chronic rhinosinusitis patients with asthma and nasal polyps. Int Forum Allergy Rhinol.2014;4(11):885–892.
50.
SolerZMMaceJCLitvackJR, et al. Chronic rhinosinusitis, race, and ethnicity. Am J Rhinol Allergy. 2012;26(2):110–116.
51.
FergusonBJBarnesLBernsteinJM, et al. Geographic variation in allergic fungal rhinosinusitis. Otolaryngol Clin North Am.2000;33(2):441–449.
52.
SpielmanDBLiebowitzAKelebeyevS, et al. Race in rhinology clinical trials: a decade of disparity. Laryngoscope. 2021;131(8):1722–1728.
53.
RussoDPThamTBardashY, et al. The effect of race in head and neck cancer: a meta-analysis controlling for socioeconomic status. Am J Otolaryngol. 2020;41(6):102624.
DarratIYaremchukKPayneS, et al. A study of adherence to the AAO-HNS “clinical practice guideline: adult sinusitis”. Ear, Nose & Throat Journal. 2014;93(8):338–352.
